Results 141 to 150 of about 208,282 (274)

Laboratory diagnosis of human visceral leishmaniasis.

open access: yesJournal of Vector Borne Diseases, 2016
Visceral leishmaniasis (VL), caused by the Leishmania donovani complex, is a vector-borne systemic disease, with a worldwide distribution causing high morbidity and mortality in the developing world.
H. Sakkas, C. Gartzonika, S. Levidiotou
semanticscholar   +1 more source

Interstitial pneumonitis in canine visceral leishmaniasis

open access: yesRevista do Instituto de Medicina Tropical de São Paulo, 1986
Forty-one naturally infected dogs with visceral leishmaniasis from an urban area of Corumbá (Mato Grosso do Sul-BRAZIL) were studied and three types of lung involvement due to visceral leishmaniasis were characterized; a cellular, a cellular-fibrotic and
M. I. S. Duarte   +5 more
doaj   +1 more source

Evidence map of diagnosis, treatment, prognosis, prevention, and control in visceral leishmaniasis. [PDF]

open access: yesRev Panam Salud Publica, 2022
Ibiapina AB   +6 more
europepmc   +1 more source

In Silico Prediction and Validation of LmGt Inhibitors Using QSAR and Molecular Docking Approaches [PDF]

open access: yesProceedings of the 2025 IEEE International Conference on Innovation in Computing and Engineering (ICE), Greater Noida, India, pp. 1 to 5, 2025
Leishmaniasis caused by Leishmania mexicana relies on Leishmania mexicana gluscose transporter (LmGT) receptors, which play an important role in glucose and ribose uptake at different stages of parasite's life cycle. Previous efforts to identify LmGT inhibitors have been primarily based on in vitro screening.
arxiv   +1 more source

A Comparison of Miltefosine and Sodium Stibogluconate for Treatment of Visceral Leishmaniasis in an Ethiopian Population with High Prevalence of HIV Infection. [PDF]

open access: yes, 2006
BACKGROUND: Antimonials are the mainstay of visceral leishmaniasis (VL) treatment in Africa. The increasing incidence of human immunodeficiency virus (HIV) coinfection requires alternative safe and effective drug regimens.
Abren Dejenie   +14 more
core   +2 more sources

e-Science initiatives in Venezuela [PDF]

open access: yesProcceedings Spanish Conference on e-Science Grid Computing, J. Casado, R. Mayo y R. Munoz (Editors) CIEMAT, Madrid Spain (2007), pp 45 - 52, 2007
Within the context of the nascent e-Science infrastructure in Venezuela, we describe several web-based scientific applications developed at the Centro Nacional de Calculo Cientifico Universidad de Los Andes (CeCalCULA), Merida, and at the Instituto Venezolano de Investigaciones Cientificas (IVIC), Caracas.
arxiv  

Fully Automated and Standardized Segmentation of Adipose Tissue Compartments by Deep Learning in Three-dimensional Whole-body MRI of Epidemiological Cohort Studies [PDF]

open access: yesarXiv, 2020
Purpose: To enable fast and reliable assessment of subcutaneous and visceral adipose tissue compartments derived from whole-body MRI. Methods: Quantification and localization of different adipose tissue compartments from whole-body MR images is of high interest to examine metabolic conditions.
arxiv  

Infectiousness in a Cohort of Brazilian Dogs: Why Culling Fails to Control Visceral Leishmaniasis in Areas of High Transmission [PDF]

open access: yes, 2002
The elimination of seropositive dogs in Brazil has been used to control zoonotic visceral leishmaniasis but with little success. To elucidate the reasons for this, the infectiousness of 50 sentinel dogs exposed to natural Leishmania chagasi infection was
Courtenay, O.   +4 more
core  

Domestic dog ownership in Iran is a risk factor for human infection with Leishmania infantum. [PDF]

open access: yes, 2002
One explanation proposed for the widespread failure to control zoonotic visceral leishmaniasis by culling infected domestic dogs is that wild canids or humans play significant roles in transmission.
Davies, Clive R   +4 more
core   +1 more source

The Contribution of Immune Evasive Mechanisms to Parasite Persistence in Visceral Leishmaniasis

open access: yesFrontiers in Immunology, 2016
Leishmania is a genus of protozoan parasites that give rise to a range of diseases called Leishmaniasis that affects annually an estimated 1.3 million people from 88 countries.
E. D. de Freitas   +4 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy